Cited by 1,970Atrial Fibrillation Management and OutcomesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Wang, Thomas J., Larson, Martin G., Levy, Daniel, Vasan, Ramachandran S., Leip, Eric P., Wolf, Philip A., D’Agostino, Ralph B., Murabito, Joanne M., Kannel, William B., Benjamin, Emelia J.·2003·Circulation

DOI 10.1161/01.cir.0000072767.89944.6e

Open this paper in CoChat — free account

Abstract

Background— Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and the combined influence of these conditions on mortality. Methods and Results— We studied participants in the Framingham Study with new-onset AF or CHF. Multivariable Cox proportional hazards models with time-dependent variables were used to evaluate whether mortality after AF or CHF was affected by the occurrence and timing of the other condition. Hazard ratios (HRs) were adjusted for time period and cardiovascular risk factors. During the study period, 1470 participants developed AF, CHF, or both. Among 382 individuals with both conditions, 38% had AF first, 41% had CHF first, and 21% had both diagnosed on the same day. The incidence of CHF among AF subjects was 33 per 1000 person-years, and the incidence of AF among CHF subjects was 54 per 1000 person-years. In AF subjects, the subsequent development of CHF was associated with increased mortality (men: HR 2.7; 95% CI, 1.9 to 3.7; women: HR 3.1; 95% CI, 2.2 to 4.2). Similarly, in CHF subjects, later development of AF was associated with increased mortality (men: HR 1.6; 95% CI, 1.2 to 2.1; women: HR 2.7, 95% CI, 2.0 to 3.6). Preexisting CHF adversely affected survival in individuals with AF, but preexisting AF was not associated with adverse survival in those with CHF. Conclusions— Individuals with AF or CHF who subsequently develop the other condition have a poor prognosis. Additional studies addressing the pathogenesis, prevention, and optimal management of the joint occurrence of AF and CHF appear warranted.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000072767.89944.6e

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Self-citation
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Self-citation
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Self-citation
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343
Congestive Heart Failure in the Community
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Show all 28 references

Research works printed but not linked: 6

10.1161/circ.84.1.2060110 · DOI
1993, Circulation, 87, VI102
1980, Arch Mal Coeur Vaiss, 73, 227
10.1161/circ.98.21.2282 · DOI
10.1161/circ.98.23.2574 · DOI
10.1161/circ.98.10.946 · DOI

Sorted by citations

Items 801–900 of 1,000

Prognostic value of ankle brachial index for future incident heart failure in patients without previous heart failure: data from the impressive predictive value of ankle brachial index for clinical long term outcome in patients with cardiovascular disease examined by ABI study
Nishimura, H., Miura, T., Minamisawa, M., Ueki, Y., Abe, N., Hashizume, N., Mochidome, T., Harada, M., Shimizu, K., Shoin, W., et al. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0873-3 · Cited by 19
Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management?
Hammond‐Haley, M., Providencia, R. A., & Lambiase, P. D. (2017) · EP Europace · doi:10.1093/europace/eux178 · Cited by 22
Atrial Fibrillation and Congestive Heart Failure
Thihalolipavan, S., & Morin, D. P. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.12.005 · Cited by 18
Association of Rate-Controlled Persistent Atrial Fibrillation With Clinical Outcome and Ventricular Remodelling in Recipients of Cardiac Resynchronization Therapy
Wilton, S. B., Kavanagh, K. M., Aggarwal, S., Philippon, F., Yee, R. K., Cowan, K. F., & Exner, D. V. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.06.004 · Cited by 17
Atrial fibrillation and chronic heart failure: interrelationship and approaches to treatment
Gagloeva, D. A., Mironov, N. Y., Laiovich, L. I., Миронова, Н. А., & Sp, G. (2021) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin2021160215 · Cited by 19
Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction
Al‐Sadawi, M., Aleem, S., Aslam, F., Jacobs, R., Stevens, G., Almasry, I. O., Singh, A., Fan, R., & Rashba, E. J. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.06.009 · Cited by 18
“However, comorbid AF with HF is associated with worse outcomes than either disease in isolation.(3,5,6) Current practice guidelines provide limited information regarding whether patients with comorbid AF/HF should be treated with rhythm or rate control.”
Background
Surgical ablation for atrial fibrillation during aortic and mitral valve surgery: A nationwide population-based cohort study
Kim, H. J., Kim, Y., Kim, M., Yoo, J. S., Kim, D., Park, D., Jung, S., Choo, S. J., & Kim, J. B. (2022) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2022.08.038 · Cited by 18
Effect of Catheter Ablation for Atrial Fibrillation in Heart Failure With Mid-Range or Preserved Ejection Fraction ― Pooled Analysis of the AF Frontier Ablation Registry and Hokuriku-Plus AF Registry ―
Tsuda, T., Kato, T., Usuda, K., Kusayama, T., Usui, S., Sakata, K., Hayashi, K., Kawashiri, M., Yamagishi, M., Takamura, M., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-22-0461 · Cited by 18
Tratamiento antiarrítmico actual de la fibrilación auricular no valvular en España. Datos del Registro FANTASIIA
Rabadán, I. R., Sánchez, M. A., Marín, F. R., Simón, M. A. Q., Siles, J. C., Peinado, R., Bertoméu, V., Cequier, A. R., Badimón, L., & Muñiz, J. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.03.007 · Cited by 18
“Acenocoumarol 948 (71,9) Warfarina 68 (5,2)”
Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon catheter versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation
Luik, A., Merkel, M., Hoeren, D., Riexinger, T., Kieser, M., & Schmitt, C. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.01.008 · Cited by 18
Atrial Fibrillation and Mortality in Critically Ill Patients: A Retrospective Study
Gupta, S., Tiruvoipati, R., & Green, C. (2015) · American Journal of Critical Care · doi:10.4037/ajcc2015319 · Cited by 18
Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant
Brown, L., & Boos, C. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.086 · Cited by 18
Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation
Berger, J. S., Peterson, E. D., Laliberté, F., Germain, G., Lejeune, D., Schein, J. R., Lefèbvre, P., Zhao, Q., & Weir, M. R. (2018) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2018.03.012 · Cited by 18
Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
Matsui, Y., Suzuki, A., Shiga, T., Arai, K., & Hagiwara, N. (2019) · Drugs - Real World Outcomes · doi:10.1007/s40801-019-0149-1 · Cited by 18
Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation
Vecchio, N. (2019) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2128 · Cited by 18
“The exclusion criteria were previous CA of AF, cardiogenic shock, contraindication to anticoagulation, left atrial appendage thrombus, pregnancy or severe comorbidities.”
BackgroundInfluential
Usefulness of Left Atrial Volume as an Independent Predictor of Development of Heart Failure in Patients With Atrial Fibrillation
Taniguchi, N., Miyasaka, Y., Suwa, Y., Harada, S., Nakai, E., Kawazoe, K., & Shiojima, I. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.049 · Cited by 20
Esophageal injury associated with catheter ablation for atrial fibrillation: Determinants of risk and protective strategies
Assis, F., Shah, R. N., Narasimhan, B., Ambadipudi, S., Bhambhani, H., Catanzaro, J. N., Calkins, H. G., & Tandri, H. S. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14513 · Cited by 18
No Impact of Atrial Fibrillation on Mortality Risk in Optimally Treated Heart Failure Patients
Tveit, A., Flønæs, B., Aaser, E., Korneliussen, K., Frøland, G., Gullestad, L. L., & Grundtvig, M. (2011) · Clinical Cardiology · doi:10.1002/clc.20939 · Cited by 18
Effects of Smoking Habit on the Prevalence of Atrial Fibrillation in Japanese Patients With Special Reference to Sex Differences
Suzuki, S. S., Sagara, K., Otsuka, T., Kano, H., Matsuno, S., Takai, H., Uejima, T., Oikawa, Y., Koike, A., Nagashima, K., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0446 · Cited by 18
Catheter ablation for atrial fibrillation results in greater improvement in cardiac function in patients with low versus normal left ventricular ejection fraction
Küçükdurmaz, Z., Kato, R., Erdem, A., Gölcük, E., Tobiume, T., Nagase, T., Ikeda, Y., Nakajima, Y., Matsumura, M., Komiyama, N., et al. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9794-6 · Cited by 18
“They are generally seen together and both of them increase the morbidity andmortality seen with either of them alone [2].”
Background
Atrial Fibrillation in Decompensated Heart Failure: Associated Factors and In-Hospital Outcome
Mendes, F. D. S. N. S., Atié, J., Garcia, M. I., Gripp, E. D. A., de Sousa, A. D., Feijó, L. A., & Xavier, S. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140123 · Cited by 18
The genetics of atrial fibrillation
Sabeh, M. K., & MacRae, C. A. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283385734 · Cited by 18
Biomarkers Determining Prognosis of Atrial Fibrillation Ablation
Tsiachris, D., Γιαννόπουλος, Γ., Deftereos, S. G., Kossyvakis, C., Tsioufis, C., Siasos, G., Oikonomou, E. K., Gatzoulis, K. A., Tousoulis, D., & Stefanadis, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180320122930 · Cited by 19
Treatment strategy and clinical outcome in Japanese patients with atrial fibrillation
Suzuki, S. S., Yamashita, T., Otsuka, T., Sagara, K., Uejima, T., Oikawa, Y., Yajima, J., Koike, A., Nagashima, K., Kirigaya, H., et al. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1121-2 · Cited by 18
“(3) The diagnosis sheets were checked by the staff who were apart from the attending physicians and patients.”
BackgroundMethod
Cardioversion of Atrial Fibrillation for Maintenance of Sinus Rhythm: A Road to Nowhere
Wyse, D. G. (2009) · Circulation · doi:10.1161/circulationaha.109.884387 · Cited by 18
Development of Congestive Heart Failure in Japanese Patients With Atrial Fibrillation
Fukuda, T., Yamashita, T., Sagara, K., Kato, T., Sawada, H., & Aizawa, T. (2007) · Circulation Journal · doi:10.1253/circj.71.308 · Cited by 17
Atrial Fibrillation and Sleep Apnoea: Guilt by Association?
Al-Falahi, Z. S., Williamson, J., & Dimitri, H. R. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.127 · Cited by 17
Development of a Novel Algorithm to Detect Atrial Fibrillation Using an Automated Blood Pressure Monitor With an Irregular Heartbeat Detector.
Ishizawa, M., Noma, T., Izumi, T., Tani, R., Inoue, T., Nasu, E., Tobiume, A., Hasui, Y., Yokoyama, S., Hamaya, H., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0349 · Cited by 12
Etiology, Pathology, and Classification of Atrial Fibrillation
Nayak, S., Natarajan, B., & Pai, R. G. (2020) · International Journal of Angiology · doi:10.1055/s-0040-1705153 · Cited by 19
Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation
Kwon, C. H., Kim, Y., Kim, M.-J., Cha, M., Cho, M. S., Nam, G., Choi, K., & Kim, J. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.05.017 · Cited by 17
Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
Johner, N., Namdar, M., & Shah, D. C. (2022) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2022.10 · Cited by 17
Atrial fibrillation/atrial flutter related mortality trends in the US population 2010–2020: Regional, racial, sex variations
Ghajar, A., Essa, M., DeLago, A. J., Parvez, A., Aryan, Z., Shalhoub, J., Hammond‐Haley, M., Hartley, A., Sargsyan, V., Salciccioli, J. D., et al. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14643 · Cited by 17
Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review
Ouyang, X., Wang, J., Chen, Q., Peng, L., Li, S., & Tang, X. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01860-1 · Cited by 17
Prevalence of Subclinical Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
Yang, E., Heckbert, S. R., Ding, J., SPRAGG, D. D., Calkins, H. G., Shah, S. J., Szklo, M., Post, W. S., & Sharma, K. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.09.023 · Cited by 17
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group
Paolillo, S., Agostoni, P., Masarone, D., Corrà, U., Passino, C., Scrutinio, D., Correale, M., Cattadori, G., Metra, M., Girola, D., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.023 · Cited by 17
Heart Failure Highlights in 2012–2013
Liu, L. C. Y., Damman, K., Lipsic, E., Maass, A. H., Rienstra, M., & Westenbrink, B. D. (2013) · European Journal of Heart Failure · doi:10.1002/ejhf.43 · Cited by 16
Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients
Jędrzejczyk‐Patej, E., Lenarczyk, R., Mazurek, M., Liberska, A., Przybylska-Siedlecka, K., Podolecki, T., Kowalczyk, J. P., Sokal, A., Leopold-Jadczyk, A., Kowalski, O., et al. (2015) · EP Europace · doi:10.1093/europace/euv095 · Cited by 17
Determinants of long-term survival in patients hospitalized for heart failure
Martínez‐Sellés, M., Martínez, E., Cortés, M., Prieto-Arévalo, R., Gallego, L., & Fernández‐Avilés, F. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328332ea96 · Cited by 17
Bidirectional association between atrial fibrillation and congestive heart failure in the elderly
O’Neal, W. T., Qureshi, W., Zhang, Z., & Soliman, E. Z. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000289 · Cited by 17
Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta‐analysis
Agasthi, P., Lee, J. Z., Amin, M., Al‐Saffar, F., Goel, V., Tseng, A. S., Almader‐Douglas, D., Killu, A. M., Deshmukh, A. J., Munoz, F. D., et al. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12146 · Cited by 16
Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry)
An, Y., Ogawa, H., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Aono, Y., Ikeda, S., Doi, K., Tsuji, H., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.048 · Cited by 17
Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
Yang, P., Kim, D., Sung, J., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84256-z · Cited by 17
The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases
Pan, Y., Xu, L., Yang, X., Chen, M., & Gao, Y. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10095-9 · Cited by 18
Combined Minimally Invasive Pulmonary Vein Isolation, Left Atrial Appendage Excision and Cardiac Resynchronization Therapy for Heart Failure: Case Report
Brizzio, M. E., Navia, J. L., Atik, F. A., Martin, D. O., Gillinov, A. M., Gonzalez‐Stawinski, G. V., Wilkoff, B. L., & Starling, R. C. (2005) · The Heart Surgery Forum · doi:10.1532/hsf98.20051114 · Cited by 17
Managing Arrhythmias in the Intensive Care Unit
Tracy, C. M., & Boushahri, A. (2014) · Critical Care Clinics · doi:10.1016/j.ccc.2014.03.009 · Cited by 17
Rhythm control agents and adverse events in patients with atrial fibrillation
Taylor, C. J., Hodgkinson, J., & Hobbs, R. F. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02426.x · Cited by 17
Prevalence and relative risk factors of atrial fibrillation in male coal miners in North China
Yu, K.-L., Xing, A., Wang, D., Qi, S., Wang, G., Chen, R., Wang, Y., Wu, S., & Jiang, H. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.002 · Cited by 17
“The prevalence of AF depends upon the population studied [1,2].”
Background
Individualized approaches to thromboprophylaxis in atrial fibrillation
Ziff, O. J., & Camm, A. J. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.10.021 · Cited by 18
“Patients with HF are more likely to develop AF, which is itself an independent risk factor for development of HF.(114) Heart failure, even in sinus rhythm, is associated with ischemic stroke.”
BackgroundInfluential
Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial
Wilton, S. B., Exner, D. V., Wyse, D. G., Yetisir, E., Wells, G. A., TANG, A. S. L., & Healey, J. S. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003807 · Cited by 17
Evaluation of the Association Between Retinal Vein Occlusion and the Risk of Atrial Fibrillation Development: A 12-Year, Retrospective Nationwide Cohort Study
Rim, T. H., Oh, J., Lee, C. S., Lee, S. C., Kang, S., & Kim, S. S. (2016) · Scientific Reports · doi:10.1038/srep34708 · Cited by 17
Progression of late postoperative atrial fibrillation in patients with tetralogy of Fallot
Ramdjan, T. T. T. K., Mouws, E. M. J. P., Teuwen, C. P., Sitorus, G. D. S., Houck, C. A., Bogers, A. J. J. C., & de Groot, N. M. S. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13369 · Cited by 17
Statin therapy in the prevention and treatment of atrial fibrillation
Lee, Y. L., Blaha, M. J., & Jones, S. R. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.11.002 · Cited by 17
Assessment of left ventricular systolic function in patients with chronic atrial fibrillation and dilated cardiomyopathy using the ratio of preceding to prepreceding R–R intervals
Tanabe, M., Onishi, K., Dohi, K., Kitamura, T., Ito, M., Nobori, T., & Nakano, T. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.05.001 · Cited by 17
“Individuals with AF or congestive heart failure who subsequently develop the other condition were reported to have a poor prognosis [2].”
Background
Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling
Gharanei, M., Shafaattalab, S., Sangha, S. S., Gunawan, M. G., Laksman, Z., Hove‐Madsen, L., & Tibbits, G. F. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.009 · Cited by 19
Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation
Kim, S. M., Jeon, E., Jung, J., & Lee, J. S. (2021) · Medicine · doi:10.1097/md.0000000000026883 · Cited by 16
“AF is considered an important risk factor for ischemic stroke (IS), congestive heart failure, and all-cause mortality.([2,3]) Although the prevalence and lifetime risk of AF in Asian populations is lower than that in Western populations, the burden in Asian populations may actually be higher due to the rapid increase…”
Background
Anticoagulation in Cardiomyopathy: Unravelling the Hidden Threat and Challenging the Threat Individually
Zhu, X., Wang, Z., Ferrari, M. W., Ferrari‐Kuehne, K., Bulter, J., Xiu-ying, X., Zhou, Q., Zhang, Y., & Zhang, J. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13597 · Cited by 17
“DCM/HF and AF are potential candidates for OAC due to a CHA2DS2-VASc score ≥ 1.(65,87,88) Although there is more experience with VKA, no data show that NOACs cannot be used in”
Background
Incidence of and risk factors for pacemaker implantation after the modified Cryo-Maze procedure for atrial fibrillation
Kakuta, T., Fukushima, S., Minami, K., Kawamoto, N., Tadokoro, N., Saiki, Y., & Fujita, T. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.10.064 · Cited by 16
Efficacy and safety of catheter ablation for atrial fibrillation in elderly patients: a systematic review and meta-analysis
França, M. R. Q., Morillo, C. A., do Carmo, A. A. L., Mayrink, M. P., de Miranda, R. C., Naback, A., Nevis, I., Silva, G. A., Ribeiro, A. L. P., & Nascimento, B. R. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01755-5 · Cited by 15
“Left ventricular dysfunction is present in 20–30% of all patients with AF, with a threefold increase in risk of heart failure [7].”
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
Winchester, C. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s26482 · Cited by 16
Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function
Kato, K., Ejima, K., Fukushima, N., Ishizawa, M., Wakisaka, O., Henmi, R., Yoshida, K., Nuki, T., Arai, K., Yashiro, B., et al. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0635-7 · Cited by 16
“Atrial fibrillation (AF) and heart failure (HF) often coexist, and AF adversely affects the prognosis in patients with congestive heart failure [1, 2].”
Background
Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: Prospective non-interventional study
BOSCH, R. F., Kirch, W., Theuer, J.-D., Pittrow, D. B., Kohlhaußen, A., Willich, S. N., & Bonnemeier, H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.053 · Cited by 16
“The condition is associated with a significant burden of morbidity and increased risk of mortality [4,5].”
Background
Dominant frequency differences in atrial fibrillation patients with and without left ventricular systolic dysfunction
Arenal, Á., Datino, T., Atéa, L., Atienza, F., González‐Torrecilla, E., Almendral, J. M., Castilla, L., Sanchez, P. L., & Fernández‐Avilés, F. (2008) · EP Europace · doi:10.1093/europace/eup053 · Cited by 16
Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primare care: a randomised clinical trial of efficacy. DOFA-AP study protocol
Collaborative Group DOFA-AP, Pérula-de-Torres, L., Martínez-Adell, M., González-Blanco, V., Baena-Díez, J. M., Martín-Rioboó, E., Rejano, J. M. P., González-Lama, J., Álvarez, R. M., Moral, R. R., et al. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-106 · Cited by 16
“One in every six strokes occur in subjects with AF [13,14], and the increased risk for ictus depends on the number of additional risk factors.”
Background
Anticoagulation in Heart Failure Without Atrial Fibrillation: Gaps and Dilemmas in Current Clinical Practice
Siliste, R., Antohi, E., Pepoyan, S., Nakou, E. S., & Vardas, P. E. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1153 · Cited by 16
Long-term trends of use of health service among heart failure patients
Rao, A., Kim, D. J., Darzi, A. W., Majeed, A., Aylin, P. P., & Bottle, A. (2018) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcy013 · Cited by 16
Prevalence and in-hospital mortality during arrhythmia-related admissions in adults with tetralogy of Fallot
Egbe, A. C., Vallabhajosyula, S., Vojjini, R., Banala, K. R., Najam, M., Faizee, F., Khalil, F. M., Ullah, M. W., & Deshmukh, A. J. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.09.001 · Cited by 16
Clinical significance of increased arterial stiffness associated with atrial fibrillation, according to Framingham risk score
Chung, G. E., Park, H. E., Lee, H., & Choi, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-84311-9 · Cited by 17
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.
Koniari, I. C., Artopoulou, E., Velissaris, D., Ainslie, M., Mplani, V., Karavasili, G., Kounis, N. G., & Tsigkas, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.11.010 · Cited by 16
“diseases, mortality, central nervous system side effects.([11]) Most specifically, AF often precedes or fol-”
Background
The Atrial Fibrillation Paradox of Heart Failure
Shelton, R. J., Clark, A. L., Kaye, G., & Cleland, J. G. F. (2009) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2009.00114.x · Cited by 16
Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States
Pan, X., Simon, T. A., Hamilton, M., & Kuznik, A. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-014-1144-8 · Cited by 16
Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation
Kato, S., Foppa, M., Roujol, S., Basha, T., Berg, S., Kissinger, K. V., Goddu, B., Manning, W. J., & Nezafat, R. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.11.073 · Cited by 17
Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation
Zhao, Q., Li, X., Dong, W., Ye, M., Cao, Y., Zhang, M., Cheng, Q., Zhou, J., Chen, G., Yu, M., et al. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0019-8 · Cited by 16
Influencia de la fibrilación auricular en la mortalidad de los pacientes con insuficiencia cardiaca con fracción de eyección preservada
Franco, J., Formiga, F., Cepeda, J. M., Llàcer, P., Arévalo-Lorido, J., Cerqueiro, J., Franco, Á. G., Epelde, F., Manzano, L., & Montero-Pérez-Barquero, M. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.06.065 · Cited by 16
“Mortalidad por insuficiencia cardiaca, n (%) A los 3 meses 82 (4,2) 58 (4,9) 24 (3,0) 0,039 A los 12 meses 178 (9,0) 113 (9,6) 65 (8,2) 0,298”
BackgroundInfluential
QTc interval, cardiovascular events and mortality in patients with atrial fibrillation
Reusser, A., Blum, S., Aeschbacher, S., Eggimann, L., Ammann, P., Erné, P., Moschovitis, G., Valentino, M. D., Shah, D. C., Schläpfer, J., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.078 · Cited by 16
History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure
Patel, R. B., Vaduganathan, M., Rikhi, A., Chakraborty, H., Greene, S. J., Hernandez, A. F., Felker, G. M., Redfield, M. M., Butler, J., & Shah, S. J. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.09.008 · Cited by 16
A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats
Dhein, S., Duerrschmidt, N., Scholl, A., Boldt, A., Schulte, J. S., Pfannmüller, B., Rojas-Gómez, D. M., Scheffler, A., Haefliger, J., Doll, N., et al. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0265-z · Cited by 16
“It has often been suggested that calcium plays an important role in the pathophysiology of AF (Brundel et al. 2001; Van Wagoner et al. 1999; Lai et al. 1999).”
Background
Prävalenz und Risikofaktoren von Vorhofflimmern in Deutschland
Schnabel, R. B., Johannsen, S. S., Wild, P. S., & Blankenberg, S. (2015) · Herz · doi:10.1007/s00059-014-4199-6 · Cited by 16
Effect of Electrode Position on the Outcome of Cardioversion
Kirchhof, P. F., Borggrefe, M., & BREITHARDT, G. E. (2003) · Cardiac Electrophysiology Review · doi:10.1023/b:cepr.0000012399.96959.ab · Cited by 16
“The hemodynamic consequences of atrial fibrillation and its thromb-embolic complications cause relevant morbidity and mortality [3,4], especially in patients with heart failure [ 5 ].”
Background
Atrial Fibrillation and Death After Myocardial Infarction
Lubitz, S. A., Magnani, J. W., Ellinor, P. T., & Benjamin, E. J. (2011) · Circulation · doi:10.1161/circulationaha.111.030171 · Cited by 15
Self-citation
Time-to-event prediction analysis of patients with chronic heart failure comorbid with atrial fibrillation: a LightGBM model
Zheng, C., Tian, J., Wang, K., Han, L., Yang, H., Ren, J. L., Li, C., Zhang, Q., Han, Q., & Zhang, Y. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02188-y · Cited by 15
“In the Framingham Heart Study, patients with heart failure comorbid with atrial fibrillation have a higher risk of mortality than those with only one disease [3].”
Background
Heart Failure Score and Outcomes in Patients with Preserved Ejection Fraction After Catheter Ablation for Atrial Fibrillation
Sumiyoshi, H., Tasaka, H., Yoshida, K., Yoshino, M., & Kadota, K. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14876 · Cited by 15
Age-Dependent Prognostic Significance of Atrial Fibrillation in Outpatients with Chronic Heart Failure: Data from the Italian Network on Congestive Heart Failure Registry
Baldasseroni, S., Orso, F., Fabbri, G., Bernardi, A. D., Cirrincione, V., Gonzini, L., Fumagalli, S., Marchionni, N., Midi, P., & Maggioni, A. P. (2010) · Cardiology · doi:10.1159/000315312 · Cited by 15
“Both diseases are frequently diagnosed in the elderly, in whom they often coexist because one predisposes the patient to the other [ , ,”
Background
Long-term outcomes of catheter ablation of atrial fibrillation in dilated cardiomyopathy
Zhao, L., Xu, K., Jiang, W., Zhou, L., Wang, Y., Zhang, X., Wu, S., & Liu, X. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.186 · Cited by 15
Recent Mortality and Morbidity Rates of Japanese Atrial Fibrillation Patients
Yamashita, T. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0002 · Cited by 15
Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation
Satoh, A., Niwano, S., Niwano, H., Kishihara, J., Aoyama, Y., Oikawa, J., Fukaya, H., Tamaki, H., & Ako, J. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0874-2 · Cited by 15
Epidemiología de la fibrilación auricular
Gómez‐Doblas, J. J., López-Garrido, M. A., Ruiz, I. E., & Barón‐Esquivias, G. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30007-3 · Cited by 16
Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study
Balsam, P., Gawalko, M. M., Peller, M., Tymińska, A., Ozierański, K., Zaleska, M., Żukowska, K., Szepietowska, K., Maciejewski, K., Grabowski, M., et al. (2018) · Medicine · doi:10.1097/md.0000000000013074 · Cited by 15
“AF and CHF are associated with increased risk for stroke and systemic embolism, and when combined have much worse outcomes.([6,7]) Moreover, even in the absence of AF, CHF is an independent risk factor for thromboembolism, ranking second only to AF as the underlying cause of cardioembolic strokes.”
Background
Screening For Atrial Fibrillation In The Community Using A Novel ECG Recorder.
Battipaglia, I., Gilbert, K., Hogarth, A. J., & Tayebjee, M. H. (2016) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1433 · Cited by 14
Heart Failure Patients with Atrial Fibrillation Benefit from Remote Patient Management: Insights from the TIM-HF2 Trial
Stegmann, T., Koehler, K., Wachter, R., Moeller, V., Zeynalova, S., Koehler, F., & Laufs, U. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12819 · Cited by 15
“High cardiac filling pressures due to HF contribute to the development of AF.(28,29) This ‘vicious cycle’ can be therapeutically addressed, e.”
Background
Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation
Blum, S., Aeschbacher, S., Meyre, P. B., Kühne, M., Rodondi, N., Beer, J. H., Ammann, P., Moschovitis, G., Bonati, L. H., Blum, M. R., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.11.028 · Cited by 15
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States
Noubiap, J. J., Thomas, G., Agbaedeng, T. A., Fitzgerald, J. L., Gallagher, C., Middeldorp, M. E., & Sanders, P. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab096 · Cited by 15
The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
Bezati, S., Velliou, M., Polyzogopoulou, E., Boultadakis, A., & Parissis, J. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac024 · Cited by 15
“Interestingly, in patients with pre-existing HF, the development of AF doubles mortality and in patients with pre-existing AF the development of HF triples mortality.(6,7) Regarding patients with cardiogenic shock (CS) and atrial tachyarrhythmia evidence is limited and is mostly related to patients with acute coronary…”
Self-reported marijuana use and cardiac arrhythmias (from the Multiethnic Study of Atherosclerosis)
Harding, B. N., Austin, T. R., Floyd, J. S., Smith, B. M., Szklo, M., & Heckbert, S. R. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.05.004 · Cited by 15
Left atrial appendage function and structure predictors of recurrent atrial fibrillation after catheter ablation: A meta-analysis of observational studies
Han, S., Liu, M., Jia, R., Cen, Z., Guo, R., Liu, G., & Cui, K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1009494 · Cited by 15
Atrial fibrillation endpoints: hospitalization
Ruskin, J. N., & Singh, J. P. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.04.004 · Cited by 15
Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm
Jędrzejczyk‐Patej, E., Lenarczyk, R., Pruszkowska, P., Kowalski, O., Mazurek, M., Sokal, A., Boidol, J., Woźniak, A., Pluta, S., Szulik, M., et al. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0110 · Cited by 15
Cardiac resynchronization therapy and atrial fibrillation.
Kamath, G. S., & Steinberg, J. S. (2009) · PubMed · Cited by 15
Exercise Training in Heart Failure Patients With Persistent Atrial Fibrillation: a Practical Approach
Cornelis, J., & MYERS, J. N. (2018) · Cardiac failure review · doi:10.15420/cfr.2018.19.2 · Cited by 15
Validation of Conventional Thromboembolic Risk Factors in a Korean Atrial Fibrillation Population ― Suggestion for a Novel Scoring System, CHA2DS2-VAK ―
Cha, M., Cho, Y., Oh, I., Choi, E., & Oh, S. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0218 · Cited by 15
Noninvasive peripheral vascular function and atrial fibrillation in the general population
Börschel, C. S., Rübsamen, N., Ojeda, F., Wild, P. S., Hoffmann, B. A., Prochaska, J. H., Gori, T., Lackner, K. J., Blankenberg, S., Zeller, T., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000002000 · Cited by 16

Authors: Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J.
Affiliations: Boston University (US)
ORCID: Wang, Thomas J.
Larson, Martin G.
Levy, Daniel
Vasan, Ramachandran S.
Wolf, Philip A.
D’Agostino, Ralph B.
Murabito, Joanne M.
Benjamin, Emelia J.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-06-17
Volume: 107
Issue: 23
Pages: 2920-2925
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000072767.89944.6e
OpenAlex: W1998083759
Cited by: 1,970
References: 28
Citations by year: 2026: 49 · 2025: 65 · 2024: 114 · 2023: 93 · 2022: 117 · 2021: 137 · 2020: 109 · 2019: 103 · 2018: 120 · 2017: 107 · 2016: 111 · 2015: 115 · 2014: 112 · 2013: 101 · 2012: 84
FWCI: 27.01
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (K24-HL-04334-01A1, N01‐HC25195, K24HL004334)
National Institute of Neurological Disorders and Stroke (5-RO1-NS-17950, R01NS017950)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: atrial fibrillation, congestive heart failure, mortality, comorbidities, prognosis, Framingham Heart Study
MeSH terms: Aged, Atrial Fibrillation, Female, Follow-Up Studies, Heart Failure, Humans, Male, Massachusetts, Middle Aged, Prognosis, Risk Factors, Cohort Studies, Comorbidity, Incidence, Multivariate Analysis, Proportional Hazards Models, Survival Analysis, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks